138 related articles for article (PubMed ID: 14643972)
1. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs.
Rama Prasad YV; Eaimtrakarn S; Ishida M; Kusawake Y; Tawa R; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Dec; 268(1-2):13-21. PubMed ID: 14643972
[TBL] [Abstract][Full Text] [Related]
2. Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself.
Hu Z; Prasad Yv R; Tawa R; Konishi T; Ishida M; Shibata N; Takada K
Int J Pharm; 2002 Mar; 234(1-2):223-35. PubMed ID: 11839453
[TBL] [Abstract][Full Text] [Related]
3. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin.
Hu Z; Tawa R; Konishi T; Shibata N; Takada K
Life Sci; 2001 Nov; 69(24):2899-910. PubMed ID: 11720093
[TBL] [Abstract][Full Text] [Related]
4. Oral solid gentamicin preparation using emulsifier and adsorbent.
Ito Y; Kusawake T; Ishida M; Tawa R; Shibata N; Takada K
J Control Release; 2005 Jun; 105(1-2):23-31. PubMed ID: 15908031
[TBL] [Abstract][Full Text] [Related]
5. Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.
Prasad YV; Puthli SP; Eaimtrakarn S; Ishida M; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Jan; 250(1):181-90. PubMed ID: 12480284
[TBL] [Abstract][Full Text] [Related]
6. Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.
Koga K; Kusawake Y; Ito Y; Sugioka N; Shibata N; Takada K
Eur J Pharm Biopharm; 2006 Aug; 64(1):82-91. PubMed ID: 16750354
[TBL] [Abstract][Full Text] [Related]
7. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer.
Rama Prasad YV; Minamimoto T; Yoshikawa Y; Shibata N; Mori S; Matsuura A; Takada K
Int J Pharm; 2004 Mar; 271(1-2):225-32. PubMed ID: 15129989
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.
Yüksel N; Karataş A; Ozkan Y; Savaşer A; Ozkan SA; Baykara T
Eur J Pharm Biopharm; 2003 Nov; 56(3):453-9. PubMed ID: 14602190
[TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
Hosny EA; Al-Shora HI; Elmazar MM
Int J Pharm; 2002 Apr; 237(1-2):71-6. PubMed ID: 11955805
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.
Hansen T; Holm P; Rohde M; Schultz K
Int J Pharm; 2005 Apr; 293(1-2):203-11. PubMed ID: 15778058
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study.
Izquierdo I; Borja J; Rovira S; Pelagio P; Torres F; Cebrecos J; García-Rafanell J
Arzneimittelforschung; 2010; 60(1):36-41. PubMed ID: 20184225
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
14. Absorption of vitamin K2 by dogs after oral administration of a soft gelatin capsule formulation containing a new emulsion-type vehicle.
Amemiya T; Mizuno S; Hayashi Y; Yuasa H; Watanabe J
J Pharm Pharmacol; 1999 Dec; 51(12):1375-80. PubMed ID: 10678491
[TBL] [Abstract][Full Text] [Related]
15. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
16. Nonionic microemulsions for oral and transdermal delivery of gentamicin.
Alkrad JA; Alruby AS
Pharmazie; 2018 Jan; 73(1):9-15. PubMed ID: 29441944
[TBL] [Abstract][Full Text] [Related]
17. Liquid Nanosize Emulsion-Filled Enteric-Coated Capsules for Colon Delivery of Immunosuppressant Peptide.
Sharma S; Sinha VR
AAPS PharmSciTech; 2018 Feb; 19(2):881-885. PubMed ID: 29043605
[TBL] [Abstract][Full Text] [Related]
18. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Kuentz M; Nick S; Parrott N; Röthlisberger D
Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
20. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
